Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCARLET-ICE
NCT07474558Phase 2Not yet recruiting
- Sponsor
- Institut Jules Bordet
- Start
- Sep 2026
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in alopecia (2 arms), sponsored by Institut Jules Bordet. Primary endpoint: Percentage of participants with hair loss at 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
alopecia
Beyond the preview
Go deeper on NCT07474558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07474558.